Shares of Sun Pharmaceuticals, India’s largest drug manufacturer, gained more than 50% over the last one year. In its latest results, the company also posted a 34% on year jump in Q4 profit. While the stock did decline slightly this week, pharma analysts are positive on the stock as the company has shown growth across key therapies. The biggest reason for optimism is Sun Pharma’s global specialty business, which exceeded USD1 billion in sales in
Related Posts
High risk of adverse reaction to two diabetes drugs: Doctors advise caution; will patients be safe?
Canadian physician William Osler is said to have once remarked that medicine is a science of uncertainty and an art of probability. The quote by Osler, known as the father of modern medicine, has of late been recalled during discussions among doctors in light of a study associated with two widely prescribed drugs used to […]
Silent epidemic: the health catastrophe India is not talking about, and why that should change
“I feel exhausted all the time.” Cheryl (name changed on the condition of anonymity), a 30-year-old artist from New Delhi, was suffering from heavy menstrual bleeding, hot flashes, and chronic fatigue. All of that prompted her to consult a gynaecologist in 2016. The diagnosis came soon enough. Cheryl had polycystic ovary syndrome (PCOS). She would […]
narayana hrudayalaya: Narayana Hrudayalaya’s shares are on a growth beat. What’s driving the hospital chain’s optimism?
Synopsis Improving financials of hospital chains, future growth prospects of the sector itself have attracted investors to hospital stocks. But while Apollo Hospitals and Max Healthcare led the gains post Covid-19, this calendar year Narayana Hrudayalaya has outperformed other major hospital stocks with a 72% rise in its share price. What lies ahead for the […]
